160 related articles for article (PubMed ID: 31257946)
21. Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
Zhu X; Kong Y; Liu Q; Lu Y; Xing H; Lu X; Yang Y; Xu J; Li N; Zhao D; Chen X; Lu Y
Pulm Pharmacol Ther; 2019 Apr; 55():50-61. PubMed ID: 30738974
[TBL] [Abstract][Full Text] [Related]
22. Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats.
Yang DB; Zhu JB; Zhu H; Zhang XS
Yao Xue Xue Bao; 2005 Dec; 40(12):1069-74. PubMed ID: 16496667
[TBL] [Abstract][Full Text] [Related]
23. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
Al-Qadi S; Grenha A; Carrión-Recio D; Seijo B; Remuñán-López C
J Control Release; 2012 Feb; 157(3):383-90. PubMed ID: 21864592
[TBL] [Abstract][Full Text] [Related]
24. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.
Shen ZG; Chen WH; Jugade N; Gao LY; Glover W; Shen JY; Yun J; Chen JF
Int J Pharm; 2012 Jul; 430(1-2):98-103. PubMed ID: 22486960
[TBL] [Abstract][Full Text] [Related]
25. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
Eedara BB; Tucker IG; Das SC
Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
[TBL] [Abstract][Full Text] [Related]
26. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance.
Patil-Gadhe A; Kyadarkunte A; Patole M; Pokharkar V
Eur J Pharm Biopharm; 2014 Sep; 88(1):169-77. PubMed ID: 25078860
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic characterization of the novel pulmonary delivery excipient fumaryl diketopiperazine.
Potocka E; Cassidy JP; Haworth P; Heuman D; van Marle S; Baughman RA
J Diabetes Sci Technol; 2010 Sep; 4(5):1164-73. PubMed ID: 20920436
[TBL] [Abstract][Full Text] [Related]
28. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
Karimi K; Katona G; Csóka I; Ambrus R
J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
[TBL] [Abstract][Full Text] [Related]
29. Insulin-micro- and nanoparticles for pulmonary delivery.
Klingler C; Müller BW; Steckel H
Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
[TBL] [Abstract][Full Text] [Related]
31. Effect of additives on insulin absorption from intratracheally administered dry powders in rats.
Todo H; Okamoto H; Iida K; Danjo K
Int J Pharm; 2001 Jun; 220(1-2):101-10. PubMed ID: 11376972
[TBL] [Abstract][Full Text] [Related]
32. Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis.
Momin MAM; Sinha S; Tucker IG; Das SC
Drug Dev Ind Pharm; 2019 Aug; 45(8):1321-1331. PubMed ID: 31014129
[TBL] [Abstract][Full Text] [Related]
33. [Local and systemic delivery of high-molecular weight drugs by powder inhalation].
Okamoto H; Danjo K
Yakugaku Zasshi; 2007 Apr; 127(4):643-53. PubMed ID: 17409693
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
Razavi Rohani SS; Abnous K; Tafaghodi M
Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
[TBL] [Abstract][Full Text] [Related]
35. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
36. Microencapsulated chitosan nanoparticles for lung protein delivery.
Grenha A; Seijo B; Remuñán-López C
Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
[TBL] [Abstract][Full Text] [Related]
37. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
38. [Recent progress of dry powder inhalation of proteins and peptides].
Zhou JY; Zhang L; Mao SR
Yao Xue Xue Bao; 2015 Jul; 50(7):814-23. PubMed ID: 26552141
[TBL] [Abstract][Full Text] [Related]
39. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Ciprofloxacin Hydrochloride Spray-Dried Microparticles for Pulmonary Delivery Using Design of Experiments.
Razuc M; Piña J; Ramírez-Rigo MV
AAPS PharmSciTech; 2018 Oct; 19(7):3085-3096. PubMed ID: 30105497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]